Concert Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch CNCE and buy or sell other stocks, ETFs, and their options commission-free!

About CNCE

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders.

CEO

Roger D. Tung, PhD

CEORoger D. Tung, PhD

Employees

—

Employees—

Headquarters

Lexington, Massachusetts

HeadquartersLexington, Massachusetts

Founded

2006

Founded2006

Employees

—

Employees—

CNCE Key Statistics

Market cap

401.95M

Market cap401.95M

Price-Earnings ratio

-2.61

Price-Earnings ratio-2.61

Dividend yield

—

Dividend yield—

Average volume

2.51M

Average volume2.51M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$8.55

52 Week high$8.55

52 Week low

$2.66

52 Week low$2.66

People also own

Based on the portfolios of people who own CNCE. This list is generated using Robinhood data, and it’s not a recommendation.